Status:

COMPLETED

Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging

Lead Sponsor:

Avinger, Inc.

Conditions:

Peripheral Artery Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

A non inferiority trial to determine the capability of optical coherence tomography (OCT) imaging to show vessel morphology in comparison to imaging provided by intravascular ultrasound imaging (IVUS)...

Detailed Description

Patients requiring diagnostic imaging of peripheral vessels to determine vessel condition and planning treatment strategy will have vessel segments imaged by both OCT and IVUS imaging catheters. The i...

Eligibility Criteria

Inclusion

  • adult
  • suspected vascular disease that might be a candidate for IVUS
  • reference vessel can accommodate imaging catheters
  • successful diagnostic imaging and removal of IVUS catheter with no adverse events

Exclusion

  • if female, pregnant or breast-feeding
  • unwilling to give informed consent

Key Trial Info

Start Date :

May 24 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT03480685

Start Date

May 24 2018

End Date

October 1 2018

Last Update

June 14 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Adventis Midwest Health

Hinsdale, Illinois, United States, 60521

2

Pottstown Hospital

Pottstown, Pennsylvania, United States, 19464